LIQUENT COMPLIMENTARY WEBINAR SERIES: COMPLYING WITH THE EMA NEW PHARMACOVIGILANCE LEGISLATION - Co-presented with Andrew Marr, Managing Director, Marr Consultancy Ltd.
TUESDAY, SEPTEMBER 13th
10:00-11:00 am EST
15:00-16:00 pm GMT
European Medicines Agency (EMA) has announced new requirements in support of the new EU pharmacovigilance legislation that will require the submission of medicinal product information for all authorized products in Europe with a deadline of 2 July 2012. This webinar will provide an overview of the changes related to EVMPD and ISO IDMP standards, timelines for implementation, and how LIQUENT can help ensure your compliance with the new legislation
Key Topics That will be covered:
•More details on the EMA announcement regarding EVMPD and ISO IDMP standards and the latest timelines for implementation
•What this means to you and what should you be doing in preparation
•How LIQUENT InSight® and Regulatory Services can help ensure your compliance with the new legislation.
•LIQUENT InSight® Platform's ability to automate generation of the automation of EVMPD XML message submission and the processing of the acknowledgement.
Please click here to register the webinar: LIQUENT COMPLIMENTARY WEBINAR SERIES: COMPLYING WITH THE EMA NEW PHARMACOVIGILANCE LEGISLATION
No comments:
Post a Comment